Table 1.
Changes in prevalence rate by age class
| 2005 | 2014 | 2005–2014 growth rate | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35–50 | 51–65 | 66–80 | Over 80 | tot | 35–50 | 51–65 | 66–80 | Over 80 | tot | 35–50 | 51–65 | 66–80 | Over 80 | tot | |
| Age | 42.3 | 57.8 | 72.4 | 85.2 | 48.9 | 42.8 | 57.6 | 72.4 | 85.8 | 50.4 | 1.3% | −0.3% | 0.0% | 0.6% | 3.1% |
| Female | 51.5% | 52.0% | 57.0% | 67.1% | 53.1% | 50.8% | 51.1% | 53.3% | 64.9% | 51.9% | −1.4% | −1.7% | −6.5% | −3.3% | −2.3% |
| Hypertension | 9.5% | 34.7% | 56.7% | 59.7% | 23.7% | 11.6% | 39.2% | 67.3% | 77.5% | 30.0% | 22.1% | 13.0% | 18.7% | 29.8% | 26.6% |
| Atrial fibrillation | 0.2% | 1.2% | 5.0% | 9.4% | 1.7% | 0.4% | 1.7% | 7.3% | 16.2% | 2.9% | 100.0% | 41.7% | 46.0% | 72.3% | 70.6% |
| Stroke | 0.3% | 1.9% | 8.0% | 14.0% | 2.7% | 0.5% | 3.3% | 13.2% | 23.6% | 4.9% | 66.7% | 73.7% | 65.0% | 68.6% | 81.5% |
| Heart failure | 0.1% | 0.5% | 2.3% | 6.9% | 0.9% | 0.1% | 0.6% | 2.8% | 9.7% | 1.3% | 0.0% | 20.0% | 21.7% | 40.6% | 44.4% |
| Heart attack (acute) | 0.1% | 0.9% | 1.6% | 1.9% | 0.6% | 0.2% | 1.2% | 2.4% | 3.2% | 1.0% | 100.0% | 33.3% | 50.0% | 68.4% | 66.7% |
| Heart attack (old) | 0.1% | 0.8% | 1.8% | 1.9% | 0.6% | 0.1% | 0.5% | 1.5% | 2.0% | 0.5% | 0.0% | −37.5% | −16.7% | 5.3% | −16.7% |
| Angina | 0.1% | 0.7% | 1.6% | 1.9% | 0.6% | 0.2% | 0.8% | 2.1% | 2.9% | 0.8% | 100.0% | 14.3% | 31.3% | 52.6% | 33.3% |
| Other ischemia (acute) | 0.0% | 0.1% | 0.2% | 0.2% | 0.1% | 0.0% | 0.2% | 0.5% | 0.6% | 0.2% | — | 100.0% | 150.0% | 200.0% | 100.0% |
| Other Ischemia (chronic) | 0.4% | 2.9% | 7.5% | 10.3% | 2.6% | 0.4% | 3.2% | 8.7% | 12.5% | 3.3% | 0.0% | 10.3% | 16.0% | 21.4% | 26.9% |
| Vascular disease | 0.3% | 1.4% | 4.3% | 5.1% | 1.4% | 0.5% | 2.5% | 8.7% | 11.5% | 3.1% | 66.7% | 78.6% | 102.3% | 125.5% | 121.4% |
| Dyslipidemia | 4.0% | 12.0% | 15.6% | 8.5% | 7.2% | 7.4% | 21.3% | 31.5% | 24.2% | 14.6% | 85.0% | 77.5% | 101.9% | 184.7% | 102.8% |
| Diabetes | 1.8% | 9.0% | 16.3% | 15.2% | 6.2% | 2.1% | 9.2% | 21.0% | 21.9% | 8.0% | 16.7% | 2.2% | 28.8% | 44.1% | 29.0% |
| Cancer | 1.3% | 4.5% | 9.4% | 10.6% | 3.7% | 1.6% | 4.9% | 11.8% | 14.9% | 4.8% | 23.1% | 8.9% | 25.5% | 40.6% | 29.7% |
| COPD | 0.3% | 1.4% | 4.2% | 6.0% | 1.5% | 0.3% | 1.1% | 3.4% | 5.5% | 1.3% | 0.0% | −21.4% | −19.0% | −8.3% | −13.3% |
| Rheumatoid arthritis | 0.3% | 0.7% | 1.1% | 1.0% | 0.5% | 0.4% | 1.1% | 1.6% | 1.7% | 0.8% | 33.3% | 57.1% | 45.5% | 70.0% | 60.0% |
| Other arthritis | 1.1% | 1.8% | 2.2% | 2.1% | 1.4% | 1.9% | 3.8% | 5.3% | 5.6% | 3.0% | 72.7% | 111.1% | 140.9% | 166.7% | 114.3% |
| Parkinson | 0.0% | 0.2% | 1.1% | 2.5% | 0.4% | 0.0% | 0.2% | 1.3% | 3.3% | 0.5% | — | 0.0% | 18.2% | 32.0% | 25.0% |
| Prescriptions | 4.4 | 10.8 | 20.6 | 23.1 | 9.1 | 4.3 | 11.7 | 27.1 | 33.9 | 11.5 | −2.3% | 8.4% | 31.7% | 47.1% | 26.4% |
| DDD prescribed | 114.0 | 357.3 | 707.5 | 774.9 | 289.4 | 119.9 | 410.2 | 990.1 | 1,178.1 | 394.1 | 5.1% | 14.8% | 39.9% | 52.0% | 36.2% |
| Visits | 0.6 | 1.1 | 1.7 | 0.9 | 0.9 | 0.4 | 0.7 | 1.3 | 1.2 | 0.7 | −30.4% | −32.1% | −19.7% | 28.6% | −22.6% |
| Lab tests and diagnostic | 7.0 | 11.2 | 16.0 | 9.0 | 9.1 | 7.6 | 12.5 | 21.8 | 20.9 | 11.6 | 8.1% | 11.5% | 36.3% | 131.3% | 27.0% |
| Observations | 295,806 | 230,004 | 178,927 | 55,886 | 1,035,984 | 329,025 | 260,336 | 189,817 | 73,807 | 1,089,777 | 11.2% | 13.2% | 6.1% | 32.1% | 5.2% |